Shareholder Michael D. Harris, Esq. led a team of attorneys from Nason Yeager in representing Bothell, WA based Cocrystal Pharma, Inc. [OTCBB: COCP] in its merger with Tucker, GA based RFS Pharma, LLC. Structured as a merger of equals, the transaction had a fully diluted market value of approximately $396 million on the closing date of November 25th.
In addition to Mr. Harris, the Nason Yeager team included shareholder Brian S. Bernstein and associate Leah E. Hutton.
The principal owner of RFS Pharma, Dr. Raymond Schinazi, was named Co-Chairman of Cocrystal Pharma together with Dr. Gary Wilcox, who remains as Chief Executive Officer. Dr. Schinazi is the Frances Winthrop Walters Professor of Pediatrics and Director of the Laboratory of Biochemical Pharmacology at Emory University.